Jim Simons - Renaissance Technologies LLC 13F Activity & Position Changes (Q4 2023)

As of Dec 31, 2023, the Renaissance Technologies LLC portfolio activity showed several notable changes in holdings, according to the latest SEC 13F filing reported on Feb 13, 2024. The activity included new positions, additions to existing holdings, reductions, and complete exits, providing a clear view of how the portfolio evolved during the quarter.

During Q4 2023, the filing reported:

These updates highlight how the portfolio adjusted across different sectors and market conditions, offering insights into allocation shifts and investment trends.

Date Symbol Type Change Qty
Q4 2023
64132K201
NeuBase Therapeutics
Buy - Position Entry
+56,967
Q4 2023
A
Agilent Technologies, Inc.
Sell - Position Exit
-234,100
Q4 2023
AA
Alcoa Corporation
Sell
-41,304
Q4 2023
AAAU
Goldman Sachs Physical Gold ETF
Buy - Position Entry
+104,500
Q4 2023
AADI
Aadi Bioscience, Inc.
Buy
+152,800
Q4 2023
AAL
American Airlines Group, Inc.
Sell
-17,030,300
Q4 2023
AAME
Atlantic American Corporation
Buy
+300
Q4 2023
AAN
Sell
-54,900
Q4 2023
AAOI
Applied Optoelectronics, Inc.
Sell
-841,179
Q4 2023
AAON
AAON, Inc.
Sell - Position Exit
-80,302
Q4 2023
AAP
Advance Auto Parts Inc.
Sell
-85,600
Q4 2023
AAPL
Apple Inc.
Sell
-1,941,510
Q4 2023
AAT
American Assets Trust, Inc.
Sell
-36,501
Q4 2023
AAXJ
iShares MSCI All Country Asia e
Sell
-5,700
Q4 2023
ABBV
AbbVie Inc.
Buy
+638,612
Q4 2023
ABCL
AbCellera Biologics Inc.
Sell
-232,550
Q4 2023
ABEO
Abeona Therapeutics Inc.
Buy
+151,556
Q4 2023
ABEV
Ambev S.A.
Sell
-178,649
Q4 2023
ABG
Asbury Automotive Group Inc
Sell - Position Exit
-21,400
Q4 2023
Buy
+6,499
Q4 2023
ABM
ABM Industries Incorporated
Buy - Position Entry
+88,100
Q4 2023
ABNB
Airbnb, Inc.
Sell
-207,456
Q4 2023
ABOS
Acumen Pharmaceuticals, Inc.
Sell - Position Exit
-87,400
Q4 2023
ABSI
Absci Corporation
Sell
-170,200
Q4 2023
ABT
Abbott Laboratories
Sell - Position Exit
-87,466
Q4 2023
AC
Associated Capital Group, Inc.
Buy
+3,103
Q4 2023
ACA
Arcosa, Inc.
Sell
-30,085
Q4 2023
ACAD
ACADIA Pharmaceuticals Inc.
Buy - Position Entry
+184,000
Q4 2023
ACCD
Accolade, Inc.
Buy
+48,500
Q4 2023
ACCO
Acco Brands Corporation
Sell
-78,800
Page 1 of 122